Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

By A. Rossebø, T. Pedersen, K. Boman, P. Brudi, J. Chambers, K. Egstrup, E. Gerdts, C. Gohlke-Bärwolf, I. Holme, Y. Kesäniemi and 6 more. New England Journal of Medicine, 2008

1,632 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/17d4be70c41b37c9911ecea1af0967a762436d86

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Rhian M. Touyz
2. Marja-Riitta Taskinen
3. Jeroen J. Bax
4. I. Graham
5. Helmut Baumgartner
6. Volkmar Falk
7. Jose Luis Zamorano
8. S. Daniels

In Surgery

1. I. Graham
2. Marja-Riitta Taskinen
3. S. Gidding
4. Alberico L. Catapano
5. Ulrich Laufs
6. R. Bilous
7. B. Vergès

Citations in the corpus

• [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. (2017, background): “Randomized trials have consistently shown that statins do not affect the progression of aortic stenosis.(112) Patients with symptoms of heart failure who are unsuitable candidates for surgery or TAVI or who are currently awaiting surgical or catheter intervention should be medically treated accordin”
• Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. (2011, methodology): “A variety of approaches have been developed for formally diagnosing FH by applying any one of several validated sets of criteria.(24,54) The best characterized are the Simon Broome Register Diagnostic Criteria for FH,(55) the Dutch Lipid Clinic Network Diagnostic Criteria for FH(54) and the US Make ”